Patient allegedly received an implant on (b)(6) 2012 via the right internal jugular vein due to deep vein thrombosis (dvt) and subarachnoid hemorrhage.The patient alleges organ/vena cava perforation.The patient further alleges spinal chronic pain, limited activity, severe muscle spasms, depression, anxiety, pulmonary embolism (pe), and bi-polar.Percutaneous device removal on 19feb2019 due to complications and injuries.(b)(6) 2012, per a report from retrieval report (attempted); ¿there is filling defect consistent with thrombus at the level of the upper part of the filter and extending above the filter is well, overall measuring in cross section 3.3x1.1cm.Impression: ivc filter is present.Ivc gram shows thrombus present at the level of the filter and above the filter within the ivc.The filter was not removed, see above for further details.¿ (b)(6) 2013, per a report from computed tomography (ct); ¿patient has an ivc filter.The distal portion of the struts of the ivc filter project slightly outside the wall of the ivc, compatible with chronic perforation.The medial leg appears to contact the right posterior wall of the aorta.The appearance of perforation is more pronounced than on the comparison ct from (b)(6) 2012.¿ (b)(6) 2019, per a report from retrieval report (successful); ¿findings: there is no thrombus within the filter.There is some tilt of the filter to the right of the ivc the top hook of the filter may be embedded.Impression: successful removal of retrievable tulip ivc filter.¿.
|
H6 patient code(s): pain (1994), depression (2361), anxiety (2328).Investigation: the following allegations have been investigated: organ/vena cava perforation, embedment , thrombus, tilt, spinal chronic pain, limited activity, severe muscle spasms, depression, anxiety, bi-polar.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Ivc occlusion/ thrombosis, new dvt, ivc stenosis as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: vena cava occlusion or thrombosis, vena cava stenosis, deep vein thrombosis.Filter tilt has been reported.Potential causes may include filter placement in ivcs with diameters larger than those specified in these instructions for use; improper deployment; manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter); and (or) a failed retrieval attempt.Excessive filter tilt may contribute to difficult or failed retrieval; vena cava wall penetration/perforation; and (or) result in loss of filter efficiency.Potential adverse events that may occur include, but are not limited to, the following: unacceptable filter tilt.Unknown if the reported spinal chronic pain, limited activity, severe muscle spasms, depression, anxiety, bi-polar are directly related to the filter and unable to identify a corresponding failure mode at this point in time.Catalog number and lot number are unknown; however, there is no evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, or that any cook device caused or contributed to or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|